Selective delivery of folate–PEG-linked, nanoemulsion-loaded aclacinomycin A to KB nasopharyngeal cells and xenograft: Effect of chain length and amount of folate–PEG linker

References

• AC Antony, C Utley, KC Van Horne, and JF Kolhouse. 1981. Isolation and characterization of a folate receptor from human placenta. J Biol Chem 256:9684–9692.
   PubMed Web of Science ®Google Scholar
• F Ciuchi, G Di Nicola, H Franz, G Gottarelli, P Mariani, and MG Ponzi Bossi. 1994. Self-recognition and self-assembly of folic acid salts: Columnar liquid crystalline polymorphism and the column growth process. J Am Chem Soc 116:7064–7071.
   Web of Science ®Google Scholar
• R Erttmann. 1983. Determination of aclacinomycin A by reversed-phase high-performance liquid chromatography. J Chromatogr 277:433–435.
   PubMed Web of Science ®Google Scholar
• H Fujita, K Ogawa, H Tone, H Iguchi, T Shomura, and S Murata. 1986. Pharmacokinetics of doxorubicin, (2″R)-4′-O-tetrahydropyranyl-adriamycin and aclarubicin. Jpn J Antibiot 39:1321–1336.
   PubMedGoogle Scholar
• A Gabizon, AT Horowitz, D Goren, D Tzemach, F Mandelbaum-Shavit, MM Qazen, and S Zalipsky. 1999. Targeting folate receptor with folate linked to extremities of poly(ethylene glycol)-grafted liposomes: in vitro studies. Bioconjug Chem 10:289–298.
   PubMed Web of Science ®Google Scholar
• A Gabizon, AT Horowitz, D Goren, D Tzemach, H Shmeeda, and S Zalipsky. 2003. In vivo fate of folate-targeted polyethylene-glycol liposomes in tumor-bearing mice. Clin Cancer Res 9:6551–6559.
   PubMed Web of Science ®Google Scholar
• A Gabizon, H Shmeeda, AT Horowitz, and S Zalipsky. 2004. Tumor cell targeting of liposome-entrapped drugs with phospholipid-anchored folic acid-PEG conjugates. Adv Drug Deliv Rev 56:1177–1192.
   PubMed Web of Science ®Google Scholar
• D Goren, AT Horowitz, D Tzemach, M Tarshish, S Zalipsky, and A Gabizon. 2000. Nuclear delivery of doxorubicin via folate-targeted liposomes with bypass of multidrug-resistance efflux pump. Clin Cancer Res 6:1949–1957.
   PubMed Web of Science ®Google Scholar
• Y Gupta, A Jain, P Jain, and SJ Jain. 2007. Design and development of folate appended liposomes for enhanced delivery of 5-FU to tumor cells. J Drug Target 15:231–240.
   PubMed Web of Science ®Google Scholar
• HE Hofland, C Masson, S Iginla, I Osetinsky, JA Reddy, CP Leamon, D Scherman, M Bessodes, and P Wils. 2002. Folate-targeted gene transfer in vivo. Mol Ther 5:739–744.
   PubMed Web of Science ®Google Scholar
• H Iguchi, Y Seryu, T Kiyosaki, S Hori, H Tone, and T Oki. 1980a. Studies on the absorption, excretion and distribution of aclacinomycin A: Absorption, excretion and distribution of 14C- or 3H-aclacinomycin A in mice, rats and rabbits. Jpn J Antibiot 33:169–178.
   PubMedGoogle Scholar
• H Iguchi, Y Matsushita, K Ohmori, S Hirano, T Kiyosaki, S Hori, H Tone, and T Oki. 1980b. Studies on the absorption, excretion and distribution of aclacinomycin A: Absorption, excretion and distribution of aclacinomycin A in mice, rabbits and dogs by photometric assay. Jpn J Antibiot 33:179–191.
   PubMedGoogle Scholar
• RJ Lee, and PS Low. 1995. Folate-mediated tumor cell targeting of liposome-entrapped doxorubicin in vitro. Biochim Biophys Acta 1233:134–144.
   PubMed Web of Science ®Google Scholar
• XQ Pan, X Zheng, G Shi, H Wang, M Ratnam, and RJ Lee. 2002. Strategy for the treatment of acute myelogenous leukemia based on folate receptor beta-targeted liposomal doxorubicin combined with receptor induction using all-trans retinoic acid. Blood 100:594–602.
   PubMed Web of Science ®Google Scholar
• XQ Pan, H Wang, and RJ Lee. 2003. Antitumor activity of folate receptor-targeted liposomal doxorubicin in a KB oral carcinoma murine xenograft model. Pharm Res 20:417–422.
   PubMed Web of Science ®Google Scholar
• AS Rait, KF Pirollo, L Xiang, D Ulick, and EH Chang. 2002. Tumor-targeting, systemically delivered antisense HER-2 chemosensitizes human breast cancer xenografts irrespective of HER-2 levels. Mol Med 8:475–486.
   PubMed Web of Science ®Google Scholar
• JA Reddy, C Abburi, H Hofland, SJ Howard, I Vlahov, P Wils, and CP Leamon. 2002. Folate-targeted, cationic liposome-mediated gene transfer into disseminated peritoneal tumors. Gene Ther 9:1542–1550.
   PubMed Web of Science ®Google Scholar
• JF Ross, H Wang, FG Behm, P Mathew, M Wu, R Booth, and M Ratnam. 1999. Folate receptor type beta is a neutrophilic lineage marker and is differentially expressed in myeloid leukemia. Cancer 85:348–357.
   PubMed Web of Science ®Google Scholar
• F Shen, JF Ross, X Wang, and M Ratnam. 1994. Identification of a novel folate receptor, a truncated receptor, and receptor type beta in hematopoietic cells: cDNA cloning, expression, immunoreactivity, and tissue specificity. Biochemistry 33:1209–1215.
   PubMed Web of Science ®Google Scholar
• T Shiokawa, Y Hattori, K Kawano, Y Ohguchi, H Kawakami, K Toma, and Y Maitani. 2005. Effect of polyethylene glycol linker chain length of folate-linked microemulsions loaded aclacinomycin A on targeting ability and antitumor effect in vitro and in vivo. Clin Cancer Res 11:2018–2025.
   PubMed Web of Science ®Google Scholar
• PJ Stevens, and RJ Lee. 2003. A folate receptor-targeted emulsion formulation for paclitaxel. Anticancer Res 23:4927–4931.
   PubMed Web of Science ®Google Scholar
• H Wang, JF Ross, and M Ratnam. 1998. Structure and regulation of a polymorphic gene encoding folate receptor type gamma/gamma′. Nucleic Acids Res 26:2132–2142.
   PubMed Web of Science ®Google Scholar
• J Wang, Y Maitani, and K Takayama. 2002. Antitumor effects and pharmacokinetics of aclacinomycin A carried by injectable emulsions composed of vitamin E, cholesterol, and PEG–lipid. J Pharm Sci 91:1128–1134.
   PubMed Web of Science ®Google Scholar
• M Wu, W Gunning, and M Ratnam. 1999. Expression of folate receptor type alpha in relation to cell type, malignancy, and differentiation in ovary, uterus, and cervix. Cancer Epidemiol Biomarkers Prev 8:775–782.
   PubMed Web of Science ®Google Scholar